THE ULTIMATE PEPTIDE PROTOCOL BIBLE
⚠ For research use only. Not for human use. Not medical advice.
Bioregulator

Chonluten

Quick summary

A short-peptide bioregulator studied in bronchial and gastric mucosa models. Research focus: short-peptide bioregulators. This page leads with SRP's low-and-slow starting dose.

Chonluten Amino acid sequence (one-letter code): EDG
Chonluten
Amino acid sequence (one-letter code): EDG
View product: Chonluten 20 mg Research Peptide Vial →
Dosing frequencyPending - to be added by SRP

Overview

A short-peptide bioregulator studied in bronchial and gastric mucosa models.

Looking for research material? Simple Research Peptides lists Chonluten 20 mg Research Peptide Vial for laboratory research use.

Mechanism

Short bioregulator peptides (2–4 amino acids) are proposed to enter cells, interact with DNA or histones, and adjust tissue-specific gene expression. Most of the evidence comes from cell and animal studies by a small number of research groups.

Research areas

Storage & reconstitution

Supplied as a freeze-dried (lyophilized) powder in a sealed vial. Unopened vials are generally kept cold and away from light. Labs usually reconstitute it with bacteriostatic or sterile water, letting the liquid run down the vial wall and swirling gently instead of shaking. The solution is then kept refrigerated.

Recommended starting dose (low and slow)

Starting doseLow end of the studied range: 300 mcg.
FrequencyPending - to be added by SRP
ReconstitutionExamples: 20 mg vial + 3 mL water = 6.67 mg/mL.

Studied higher doses

Studies have used doses up to the amounts below. Higher doses can be dangerous. Whether a person can reach them safely depends on height, weight, activity level, training and pre-existing conditions. We recommend following the lower starting dose above, and contacting SRP with any questions.

Highest amount reported in studiesTop of the studied range: 300 mcg. These are range tops, not verified ceilings.

Route and timing

Route: Subcutaneous injection after reconstitution is the route most often described in research protocols.
Timing: Pending - to be added by SRP

Cycle length and repeat

Pending - to be added by SRP

Half-life

Approximate, for Bobby's review: Not well characterized in published research.

Side effects

Pending - to be added by SRP

Suggested bloodwork and monitoring

Draft, for Bobby's review: CBC and comprehensive metabolic panel (kidney and liver function, electrolytes) before starting and again after a few weeks.

Cautions

Pending - to be added by SRP

Reconstitution calculator

Math aid only. It converts the numbers you enter; it is not dosing advice. For research use only. Prefilled with this page's vial size, reconstitution and low-and-slow starting dose where known; change any value.

Frequently asked questions

What is Chonluten studied for?

In research it is studied for short-peptide bioregulators. Short bioregulator peptides (2–4 amino acids) are proposed to enter cells, interact with DNA or histones, and adjust tissue-specific gene expression.

How is Chonluten given in research?

Subcutaneous injection after reconstitution is the route most often described in research protocols. SRP has not yet published a frequency for this compound.

What amount should a researcher start with?

This page lists SRP's low-and-slow starting dose in the Recommended starting dose section. Higher amounts that appear in studies are listed separately with their safety context. Start with the lower dose and contact SRP with any questions.

Related peptides

Last updated: October 19, 2026

⚠ For research use only. Not for human use. Not medical advice.